{
    "medicine_id": "fae2021d283e65b1075caf24bf6e472aa8bedca4",
    "platform_id": "10704",
    "metadata": {
        "name": "Atazanavir Zentiva 300 mg hard capsules",
        "composition": "Each capsule contains 300 mg of atazanavir as sulphate",
        "clinical_particulars": {
            "therapeutic_indications": "Atazanavir Zentiva capsules co administered with low dose ritonavir are indicated for the treatment of HIV 1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products see section 4 2 Based on available virological and clinical data from adult patients no benefit is expected in patients with strains resistant to multiple protease inhibitors 4 PI mutations The choice of atazanavir in treatment experienced adult and paediatric patients should be based on individual viral resistance testing and the patient s treatment history see sections 4 4 and 5 1",
            "contraindications": {
                "disease": "Hypersensitivity to the active substance or to any of the excipients listed in section 6 1 Atazanavir is contraindicated in patients with severe hepatic insufficiency see sections 4 2 4 4 and 5 2 Atazanavir with ritonavir is contraindicated in patients with moderate hepatic insufficiency see sections 4 2 4 4 and 5 2 Co administration with simvastatin or lovastatin see section 4 5 Combination of rifampicin see section 4 5 Combination of the PDE5 inhibitor sildenafil when used for the treatment of pulmonary arterial hypertension PAH only see section 4 5 For co administration of sildenafil for the treatment of erectile dysfunction see sections 4 4 and 4 5 Co administration with medicinal products that are substrates of the CYP3A4 isoform of cytochrome P450 and have narrow therapeutic windows e g quetiapine lurasidone alfuzosin astemizole terfenadine cisapride pimozide quinidine bepridil triazolam midazolam administered orally for caution on parenterally administered midazolam see section 4 5 lomitapide and ergot alkaloids particularly ergotamine dihydroergotamine ergonovine methylergonovine see section 4 5 Co administration with grazoprevir containing products including elbasvir grazoprevir fixed dose combination see section 4 5 Co administration with glecaprevir pibrentasvir fixed dose combination see section 4 5 Co administration with products containing St John s wort Hypericum perforatum see section 4 5",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Lactose monohydrate;Crospovidone (Type B);Magnesium stearate;Titanium dioxide (E171);Gelatine;Indigo carmine (E132);Black iron oxide (E172);Red iron oxide (E172);Yellow iron oxide (E172)",
                "incompatibilities": "Not applicable."
            }
        },
        "revision_date": "2022-02-12"
    }
}